Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 6.07753 | 83 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 6.33803 | 84 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 6.31788 | 85 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 6.3881 | 84 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.96319 | 82 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.82983 | 83 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.38139 | 79 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 6.00067 | 83 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.62533 | 80 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 6.37167 | 85 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 6.10274 | 83 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 6.35253 | 84 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.65655 | 80 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 6.07708 | 83 |